Thermo Fisher Launching RUO Women's Health Panel as Clinical PCR Strategy Coalesces | GenomeWeb

NEW YORK (GenomeWeb) – Thermo Fisher Scientific is in the midst of rolling out a qPCR-based research-use-only multi-target women's health panel based on its TaqMan chemistry and OpenArray architecture, company officials said recently.

The panel will feature assays for 34 total organisms along with controls, and will be primarily for use on the company's QuantStudio 12K Flex instrument. It is currently in the "soft launch" phase but will be fully commercially available by November, company officials said.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Science this week: genetic analysis of pollutant-tolerant fish, and more.

Researchers have found a rare carbapenem resistance gene on a US pig farm, NBC News reports.

New York officials are considering the use of a familial DNA search to get a lead on a suspect in the strangulation death of a runner.

NIH Director Francis Collins has selected a retired Army major general and cardiologist for the CEO spot at the agency's embattled Clinical Center.